<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39449127</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2200-6133</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Pneumonia (Nathan Qld.)</Title><ISOAbbreviation>Pneumonia (Nathan)</ISOAbbreviation></Journal><ArticleTitle>Clinical implications of persistently increased blood urea nitrogen/serum creatinine ratio (PI-BUN/Cr) in severe COVID-19 patients.</ArticleTitle><Pagination><StartPage>20</StartPage><MedlinePgn>20</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41479-024-00140-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with COVID-19 may experience a persistent increase in the blood urea nitrogen over creatinine ratio (PI-BUN/Cr). Its elevation could reflect multiple underlying pathophysiological processes beyond prerenal injury but also warrants nuanced interpretation due to its complex interplay with various factors, underscoring the importance of investigating its effects on mortality and acute kidney injury in this population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analized a retrospective and longitudinal cohort of patients admitted to a single center in Mexico City for patients with severe COVID-19. Between March 5, 2020 and August 25, 2021, we included patients with confirmed positive diagnosis for SARS-CoV-2, age &gt; 18 years, disease severity was defined by clinical data of respiratory distress syndrome and a ratio of partial oxygen pressure to inspired oxygen fraction &lt; 300 mmHg on admission. We excluded patients with End Stage Kidney Disease. Data was obtained from electronic medical records. PI-BUN/Cr was defined as an increase in the BUN/Cr ratio &gt; 30 in more than 60% of measurements in the hospital. The outcomes included: risk factors to mortality and AKI in-hospital.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort included 3,007 patients with a median age of 54.6 ± 14.5 years. 35% of patients died; 44.6% developed PI-BUN/Cr ratio and 71.4% AKI. Mortality was associated with older age &gt; 60 years [Hazard ratio (HR)] = 1.45, 95% CI: 1.28-1.65; p &lt; 0.001); male (HR 1.25, 95% CI 1.09-1.44; p = 0.002) and AKI (HR 3.29, 95% CI 2.42-4.46; p &lt; 0.001); PI-BUN/CR &amp; Non-AKI (HR = 2.82, 95% CI: 1.61-4.93; p &lt; 0.001); Non PI-BUN/CR &amp; AKI (HR = 5.47, 95% CI: 3.54-8.44; p &lt; 0.001); and PI-BUN/CR &amp; AKI (HR = 4.26, 95% CI: 2.75-6.62, p &lt; 0.001). Only hiperuricemia was a risk factor for AKI (HR = 1.71, 95% CI: 1.30-2.25, p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While PI-BUN/Cr alone may not directly associate with mortality, its capacity to sub-phenotype patients according to their AKI status holds significant promise in offering valuable insights into patient prognosis and outcomes. Understanding the nuanced relationship between PI-BUN/Cr and AKI enhances our comprehension of renal function dynamics. It equips healthcare providers with a refined tool for risk stratification and personalized patient management strategies.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Casas Aparicio</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Titular de la Coordination de Nefrología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fernández Plata</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Higuera Iglesias</LastName><ForeName>Anjarath</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Martínez Briseño</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México. mb3david@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claure-Del Granado</LastName><ForeName>Rolando</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division de Nefrología, Cochabamba Bolivia and IIBISMED, Facultad de Medicina, Universidad Mayor de San Simón, Hospital Obrero No. 2 - CNS, Cochabamba, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castillejos Lopez</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México. mcastillejos@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vázquez Pérez</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratorio de Biología Molecular de Enfermedades Emergentes y EPOC, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarado Vásquez</LastName><ForeName>Noé</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departmento de Investigación en Biomedicina Molecular e Investigación Translacional, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velázquez Cruz</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratorio de Genómica del Metabolismo Óseo, Instituto Nacional de Medicina Genómica, Periferico Sur 4809, Ciudad de México, 14610, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández Silva</LastName><ForeName>Graciela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratorio de Biología Molecular, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SecciÓn de Estudios de Posgrado e InvestigaciÓn, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz MirÓn s/n, Col. Casco de Santo Tomas, Miguel Hidalgo, Ciudad de México, 11340, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarena</LastName><ForeName>Ángel</ForeName><Initials>Á</Initials><AffiliationInfo><Affiliation>Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas Lara</LastName><ForeName>Citlaltepetl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratorio de Patología, Instituto Nacional de Neurología y Neurocirugía "Manuel Velazco Suarez", Insurgentes Sur 3877, Ciudad de México, 14269, México.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Neuropatologia, Instituto Nacional de Neurología y Neurocirugia, Manuel Velasco Suarez, Insurgentes Sur 3877, Ciudad de México, 14269, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tena Suck</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratorio de Patología, Instituto Nacional de Neurología y Neurocirugía "Manuel Velazco Suarez", Insurgentes Sur 3877, Ciudad de México, 14269, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montes de Oca Ambriz</LastName><ForeName>Iñaki</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala (Programa MEDICI), Universidad Nacional Autónoma de México, Av. de los Barrios 1, Tlalnepantla de Baz, Ciudad de México, 54090, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz Toledo</LastName><ForeName>Oswaldo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala (Programa MEDICI), Universidad Nacional Autónoma de México, Av. de los Barrios 1, Tlalnepantla de Baz, Ciudad de México, 54090, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arvizu Serrano</LastName><ForeName>Vianey</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala (Programa MEDICI), Universidad Nacional Autónoma de México, Av. de los Barrios 1, Tlalnepantla de Baz, Ciudad de México, 54090, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almazan Chaparro</LastName><ForeName>Yared</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Superiores Iztacala (Programa MEDICI), Universidad Nacional Autónoma de México, Av. de los Barrios 1, Tlalnepantla de Baz, Ciudad de México, 54090, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Soto</LastName><ForeName>Edgar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México, 04510, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Espíndola</LastName><ForeName>Luz María Torres</ForeName><Initials>LMT</Initials><AffiliationInfo><Affiliation>Laboratorio de Farmacología, Instituto Nacional de Pediatría, Insurgentes Sur 3700, Ciudad de México, 04530, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Aquino-Gálvez</LastName><ForeName>Arnoldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Titular de la Coordination de Nefrología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Ciudad de México, 14080, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ahumada Topete</LastName><ForeName>Victor Hugo</ForeName><Initials>VH</Initials><AffiliationInfo><Affiliation>Unidad de Epidemiología Hospitalaria e Infectología, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Ciudad de México, 14080, CP, México.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pneumonia (Nathan)</MedlineTA><NlmUniqueID>101663459</NlmUniqueID><ISSNLinking>2200-6133</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PI-BUN/Cr and AKI</Keyword><Keyword MajorTopicYN="N">Sub-phenotype</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39449127</ArticleId><ArticleId IdType="doi">10.1186/s41479-024-00140-0</ArticleId><ArticleId IdType="pii">10.1186/s41479-024-00140-0</ArticleId><ArticleId IdType="pmc">PMC11515407</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London England). 2020;395(10229):1033–4. 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum N, Dichoso CC, Carlton CE. Blood urea nitrogen and serum creatinine. Physiology and interpretations. Urology. 1975;5(5):583-8. 10.1016/0090-4295(75)90105-3. PMID: 1093306.</Citation><ArticleIdList><ArticleId IdType="pubmed">1093306</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ran J, Jiang T. Urea. Subcell Biochem. 2014;73:7–29. 10.1007/978-94-017-9343-8_2.</Citation><ArticleIdList><ArticleId IdType="pubmed">25298336</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjendra Y, Mana A, Espejo AF, Akgun AP, Millan Y, Gomez-Fernandez NC, C., Cray C. Predicting Disease Severity and Outcome in COVID-19 patients: a review of multiple biomarkers. Arch Pathol Lab Med. 2020;144(12):1465–74. 10.5858/arpa.2020-0471-SA.</Citation><ArticleIdList><ArticleId IdType="pubmed">32818235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunst J, Kashani KB, Hermans G. The urea-creatinine ratio as a novel biomarker of critical illness-associated catabolism. Intensive Care Med. 2019;45(12):1813–5. 10.1007/s00134-019-05810-y.</Citation><ArticleIdList><ArticleId IdType="pubmed">31620835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis C, Bret A, Janer A, Guido O, Bouzgarrou R, Dopeux L, Hernandez G, Mascle O, Calvet L, Thouy F, Grapin K, Couhault P, Kinda F, Laurichesse G, Bonnet B, Adda M, Boirie Y, Souweine B. Association of nitrogen balance trajectories with clinical outcomes in critically ill COVID-19 patients: a retrospective cohort study. Clin Nutr. 2022;41(12):2895–902. 10.1016/j.clnu.2022.08.023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9444301</ArticleId><ArticleId IdType="pubmed">36109282</ArticleId></ArticleIdList></Reference><Reference><Citation>Beier K, Eppanapally S, Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of normal creatinine. Crit Care Med. 2011;39(2):305–13. 10.1097/CCM.0b013e3181ffe22a.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448784</ArticleId><ArticleId IdType="pubmed">21099426</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, L., Chaudhary, K., Saha, A., Chauhan, K., Vaid, A., Zhao, S., Paranjpe, I.,Somani, S., Richter, F., Miotto, R., Lala, A., Kia, A., Timsina, P., Li, L., Freeman,R., Chen, R., Narula, J., Just, A. C., Horowitz, C., Fayad, Z., … on behalf of the Mount Sinai COVID Informatics Center (MSCIC) (2021). AKI in Hospitalized Patients with COVID-19. Journal of the American Society of Nephrology: JASN, 32(1), 151–160. https://doi.org/10.1681/ASN.2020050615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G, Maida M, Morreale GC, Licata M, Renzulli M, Cremon C, Stanghellini V, Barbara G. Gastrointestinal bleeding in COVID-19 patients: a systematic review with Meta-analysis. Can J Gastroenterol Hepatol. 2021;2021:2534975. 10.1155/2021/2534975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429023</ArticleId><ArticleId IdType="pubmed">34513750</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata A, Kasai T, Matsue Y, Matsumoto H, Yatsu S, Kato T, Suda S, Hiki M, Takagi A, Daida H. Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure. Heart Vessels. 2018;33(8):877–85. 10.1007/s00380-018-1135-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">29417223</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaguma D, Koide S, Ito E, Takahashi K, Hayashi H, Hasegawa M, Yuzawa Y, AICOPP group. Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study. Clin Exp Nephrol. 2018;22(2):353–64. 10.1007/s10157-017-1458-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">28766029</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinfeld DA, Bargouthi H, Niaz Q, Carvounis CP. Massive and disproportionate elevation of blood urea nitrogen in acute azotemia. Int Urol Nephrol. 2002;34(1):143–5. 10.1023/a:1021346401701.</Citation><ArticleIdList><ArticleId IdType="pubmed">12549657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ok F, Erdogan O, Durmus E, Carkci S, Canik A. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93(2):786–93. 10.1002/jmv.26300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405288</ArticleId><ArticleId IdType="pubmed">32662893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Lin S, Xie Y, Mo S, Huang Q, Ge H, Shi Z, Li S, Zhou D. Association between BUN/creatinine ratio and the risk of in-hospital mortality in patients with trauma-related acute respiratory distress syndrome: a single-centre retrospective cohort from the MIMIC database. BMJ open. 2023;13(4):e069345. 10.1136/bmjopen-2022-069345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10151966</ArticleId><ArticleId IdType="pubmed">37116992</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M, Verwaest C, Van der Vorst E, Lauwers P, Bouillon R, Bowers CY. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab. 1998;83(2):309–19. 10.1210/jcem.83.2.4575.</Citation><ArticleIdList><ArticleId IdType="pubmed">9467533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB, Alghuyaythat WKZ, Almutairi SB. LONG COVID: an insight. Eur Rev Med Pharmacol Sci. 2021;25(17):5561–77. 10.26355/eurrev_202109_26669.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines RW, Zolfaghari P, Wan Y, Pearse RM, Puthucheary Z, Prowle JR. Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma. Intensive Care Med. 2019;45(12):1718–31. 10.1007/s00134-019-05760-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31531715</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthucheary, Z. A., Astin, R., Mcphail, M. J. W., Saeed, S., Pasha, Y., Bear, D. E.,Constantin, D., Velloso, C., Manning, S., Calvert, L., Singer, M., Batterham, R. L.,Gomez-Romero, M., Holmes, E., Steiner, M. C., Atherton, P. J., Greenhaff, P., Edwards,L. M., Smith, K., Harridge, S. D., … Montgomery, H. E. (2018). Metabolic phenotype of skeletal muscle in critical illness. Thorax, 73(10), 926–935. https://doi.org/10.1136/thoraxjnl-2017-211073.</Citation><ArticleIdList><ArticleId IdType="pubmed">29980655</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kolic I, Purdell-Lewis J, Taylor R, Pearse RM, Kirwan CJ. Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrology: CJASN. 2014;9(6):1015–23. 10.2215/CJN.11141113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046736</ArticleId><ArticleId IdType="pubmed">24742481</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Hodgson CL, Pilcher D, Bailey M, van Lint A, Chavan S, Bellomo R. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respiratory Med. 2016;4(7):566–73. 10.1016/S2213-2600(16)30098-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27155770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sklar AH, Riesenberg LA, Ur Rehman A, Smith S, Rivera-Padilla H. Prerenal azotemia: differentiation of hyperureagenesis from renal hypoperfusion using urinary urea nitrogen data. Int J Artif Organs. 1996;19(3):164–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8675360</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain-Syed F, Slutsky AS, Ronco C. Lung-kidney cross-talk in the critically ill patient. Am J Respir Crit Care Med. 2016;194(4):402–14. 10.1164/rccm.201602-0420CP.</Citation><ArticleIdList><ArticleId IdType="pubmed">27337068</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group, Horby, P., Lim, W. S., Emberson, J. R., Mafham, M.,Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E.,Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L.C., Faust, S. N., Jaki, T., … Landray, M. J. (2021). Dexamethasone in Hospitalized Patients with Covid-19. The New England journal of medicine, 384(8), 693–704. https://doi.org/10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Siew ED, Matheny ME. Choice of reference serum creatinine in defining acute kidney Injury. Nephron. 2015;131(2):107–12. 10.1159/000439144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4618709</ArticleId><ArticleId IdType="pubmed">26332325</ArticleId></ArticleIdList></Reference><Reference><Citation>KDIGO Clinical Practice Guideline for Acute Kidney Injury. Published. March 2012. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf. Accessed: August 12, 2021.</Citation></Reference><Reference><Citation>Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2014;63(5):820–34. 10.1053/j.ajkd.2013.12.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001724</ArticleId><ArticleId IdType="pubmed">24485147</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease. Improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.</Citation></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38. 10.1016/j.kint.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ma X. Acute respiratory failure in COVID-19: is it typical ARDS? Crit Care (London England). 2020;24(1):198. 10.1186/s13054-020-02911-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202792</ArticleId><ArticleId IdType="pubmed">32375845</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachoin JS, Daher R, Moussallem C, Milcarek B, Hunter K, Schorr C, Abboud M, Henry P, Weisberg LS. The fallacy of the BUN:creatinine ratio in critically ill patients. Nephrol dialysis Transplantation: Official Publication Eur Dialysis Transpl Association - Eur Ren Association. 2012;27(6):2248–54. 10.1093/ndt/gfr705.</Citation><ArticleIdList><ArticleId IdType="pubmed">22207331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman J, Dhakal M, Patel B, Hamburger R. Community-acquired acute renal failure. Am J Kidney Diseases: Official J Natl Kidney Foundation. 1991;17(2):191–8. 10.1016/s0272-6386(12)81128-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">1992662</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Bagshaw S, Langenberg C, Ronco C. Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol. 2007;156:1–9. 10.1159/000102008.</Citation><ArticleIdList><ArticleId IdType="pubmed">17464109</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara ST, Bhatraju PK, Stanski NL, et al. Subphenotypes in acute kidney injury: a narrative review. Crit Care. 2022;26:251. 10.1186/s13054-022-04121-x).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9389711</ArticleId><ArticleId IdType="pubmed">35986336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan K, Pattharanitima P, Piani F, Johnson RJ, Uribarri J, Chan L, Coca SG. Prevalence and outcomes Associated with Hyperuricemia in Hospitalized patients with COVID-19. Am J Nephrol. 2022;53(1):78–86. 10.1159/000520355. Epub 2021 Dec 9. PMID: 34883482; PMCID: PMC8805068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805068</ArticleId><ArticleId IdType="pubmed">34883482</ArticleId></ArticleIdList></Reference><Reference><Citation>ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33. 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613–28. 10.1007/s10735-020-09915-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Chang R, Riyadh ICU, Program Users Group. Correlation between the AKI classification and outcome. Crit Care (London England). 2008;12(6):R144. 10.1186/cc7123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646305</ArticleId><ArticleId IdType="pubmed">19019254</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider AG, Bellomo R. Urinalysis and pre-renal acute kidney injury: time to move on. Crit Care (London England). 2013;17(3):141. 10.1186/cc12676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672654</ArticleId><ArticleId IdType="pubmed">23659200</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisler G, Brandt T, Ostovar GA, Taylor MD, Shah S. Procalcitonin levels in identifying bacterial infections in children with and without COVID-19. Infect Dis Clin Microbiol. 2023;5(4):287–91. 10.36519/idcm.2023.300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10986730</ArticleId><ArticleId IdType="pubmed">38633859</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand, M., Bagshaw, S. M., Bhatraju, P. K., Bihorac, A., Caniglia, E., Khanna, A.K., Kellum, J. A., Koyner, J., Harhay, M. O., Zampieri, F. G., Zarbock, A., Chung,K., Liu, K., Mehta, R., Pickkers, P., Ryan, A., Bernholz, J., Dember, L., Gallagher,M., Rossignol, P., … Ostermann, M. (2024). Sepsis-associated acute kidney injury:recent advances in enrichment strategies, sub-phenotyping and clinical trials. Critical care (London, England), 28(1), 92. https://doi.org/10.1186/s13054-024-04877-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10958912</ArticleId><ArticleId IdType="pubmed">38515121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Wiedermann W, Joannidis M. Causal relationship between hypoalbuminemia and acute kidney injury. World J Nephrol. 2017;6(4):176–87. 10.5527/wjn.v6.i4.176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5500455</ArticleId><ArticleId IdType="pubmed">28729966</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323–45. 10.1146/annurev-physiol-021113-170343.</Citation><ArticleIdList><ArticleId IdType="pubmed">25422986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherghina ME, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric acid and oxidative stress-relationship with Cardiovascular, metabolic, and renal impairment. Int J Mol Sci. 2022;23(6):3188. 10.3390/ijms23063188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949471</ArticleId><ArticleId IdType="pubmed">35328614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Matavelli L, Frohlich ED. Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006;8(2):120–4. 10.1007/s11906-006-0007-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">16672144</ArticleId></ArticleIdList></Reference><Reference><Citation>Moledina DG, Parikh CR. Phenotyping of Acute kidney Injury: beyond serum creatinine. Semin Nephrol. 2018;38(1):3–11. 10.1016/j.semnephrol.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5753429</ArticleId><ArticleId IdType="pubmed">29291759</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal failure Study Group. Kidney Int. 1996;50(3):811–8. 10.1038/ki.1996.380.</Citation><ArticleIdList><ArticleId IdType="pubmed">8872955</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Aparicio GA, León-Rodríguez I, Alvarado-de la Barrera C, González-Navarro M, Peralta-Prado AB, Luna-Villalobos Y, Velasco-Morales A, Calderón-Dávila N, Ormsby CE, Ávila-Ríos S. Acute kidney injury in patients with severe COVID-19 in Mexico. PLoS ONE. 2021;16(2):e0246595. 10.1371/journal.pone.0246595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870064</ArticleId><ArticleId IdType="pubmed">33556150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–23. 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner JL, Coca SG, Thiessen-Philbrook H, Patel UD, Shlipak MG, Garg AX, Parikh CR, Investigating Biomarker Endpoints for Acute Kidney Injury TRIBE-AKI Consortium. Translational Research Investigating Biomarker Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium, &amp; Translational Research (2015). Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR. American journal of kidney diseases: the official journal of the National Kidney Foundation, 66(6), 1006–1014. 10.1053/j.ajkd.2015.07.027</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658239</ArticleId><ArticleId IdType="pubmed">26386737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst AA, Haynes ML, Nick TG, Weiss SJ. Usefulness of the blood urea nitrogen/creatinine ratio in gastrointestinal bleeding. Am J Emerg Med. 1999;17(1):70 – 2. 10.1016/s0735-6757(99)90021-9. PMID: 9928705.</Citation><ArticleIdList><ArticleId IdType="pubmed">9928705</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto K, Prowle JR. COVID-19-associated AKI. Curr Opin Crit Care. 2022;28(6):630–7. 10.1097/MCC.0000000000000988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9612421</ArticleId><ArticleId IdType="pubmed">36194146</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza López G, Morales Villar AB, Bueno T, Lozada Hernández AP, García Cortes J, L. R., Maldonado Hernández J. Risk factors associated with glomerular filtration rate in Mexican adults with type 2 diabetes mellitus. Endocrinologia Diabetes Y Nutricion. 2024;71(2):44–52. 10.1016/j.endien.2024.03.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">38493012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CC, Bharadwa S, Foley OW, Domenech I, Vega B, Towner M, Barber EL. Low serum creatinine levels are associated with major post-operative complications in patients undergoing surgery with gynecologic oncologists. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2024;ijgc–2024. 10.1136/ijgc-2024-005308. Advance online publication.</Citation><ArticleIdList><ArticleId IdType="pubmed">38627036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>